2022
Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study
Bandeira L, Puga M, Croda J, Pompílio M, Amianti C, de Rezende G, Motta-Castro A. Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study. Frontiers In Microbiology 2022, 12: 740245. PMID: 35126323, PMCID: PMC8815966, DOI: 10.3389/fmicb.2021.740245.Peer-Reviewed Original ResearchHTLV infectionCross-sectional studyEnzyme-linked immunosorbent assayHTLV-1New casesHuman T-lymphotropic virus (HTLV) infectionAnti-HTLV antibodiesHTLV proviral DNAProspective cohort studyWestern blot methodHarm reduction measuresBrazilian general populationHTLV transmissionCohort studyMulticenter studySerological evidenceVirus infectionPrevalence ratesHigh riskGeneral populationPreventive interventionsHTLV-2Risk behaviorsInfectionProviral DNA
2017
Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil
Puga M, Bandeira L, Pompilio M, Croda J, de Rezende G, Dorisbor L, Tanaka T, Cesar G, Teles S, Simionatto S, Novais A, Nepomuceno B, Castro L, do Lago B, Motta-Castro A. Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil. PLOS ONE 2017, 12: e0169195. PMID: 28060860, PMCID: PMC5218405, DOI: 10.1371/journal.pone.0169195.Peer-Reviewed Original ResearchConceptsHCV infectionCohort studyHCV RNASectional studyInjecting-drug useNew HCV infectionsHCV risk behaviorsCross-sectional studyHCV exposureHepatitis CHIV positivityEffective intervention strategiesAssociated FactorsClinical evaluationIndependent associationOverall prevalenceRisk factorsIncidence rateBlood samplesDrug useNew casesRisk behaviorsInfectionHigh frequency ratePrevalence